Rowden Adam K, Fasano Charles J
Department of Emergency Medicine, Albert Einstein Medical Center, Philadelphia, PA 19141, USA.
Emerg Med Clin North Am. 2007 May;25(2):347-56; abstract viii. doi: 10.1016/j.emc.2007.02.010.
There are several classes of oral diabetes medications available in the United States, including sulfonylureas, meglitinides, biguanides, glitazones, and alpha-glucosidase inhibitors. These different classes have various mechanisms of action, giving each class a unique potential for toxicity that necessitates a distinct approach to evaluation, treatment, and disposition of each class of drug. The practicing emergency physician must have an understanding of these differences to safely care for patients exposed to these medications.
在美国有几类口服糖尿病药物可供使用,包括磺脲类、格列奈类、双胍类、噻唑烷二酮类和α-葡萄糖苷酶抑制剂。这些不同的类别有各种作用机制,使每一类都有独特的潜在毒性,这就需要对每一类药物采取不同的评估、治疗和处理方法。执业急诊医师必须了解这些差异,以便安全地护理接触这些药物的患者。